In addition, studies have shown that PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils, which means that the use of PTB1B inhibitors in patients with severe viral pneumonia may have a preventive effect on ALI/ARDS (31). Here, CXCR4 is linked to viral pneumonia.